AzTrials
AzTrials

Sun ProtectionNCT07481344

SunBeast: Evaluating UV Protective Behaviors and Education Interventions Among Ultrarunners

A study testing SunBeast Educational module in people with Sun Protection, run by University of Michigan Rogel Cancer Center at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Participants will be randomly assigned to either the intervention or control group using concealed allocation. The intervention-comprising targeted educational materials and behavioral prompts-will be delivered over three months preceding race day. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Sun Protection
What is being tested?
SunBeast Educational module
Could I receive a placebo?
No, everyone receives an active treatment
How many people
110 participants
Where
1 siteUnited States
Study dates
May 2027to May 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Must be 18 years or older
  • 2026 registered WSER runner
  • Understand English

Who cannot join

  • Not Applicable

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site
  • University of Michigan Rogel Cancer Center

    Ann Arbor, Michigan, 48109

    Lauren Yoder, 734-936-8051, yoderl@med.umich.edu

    Scott McLean, MD

Other trials in United States

About this study

Official title: SunBeast: Evaluating UV Protective Behaviors and Education Interventions Among Ultrarunners at the Western States Endurance Run

Participants will be randomly assigned to either the intervention or control group using concealed allocation. The intervention-comprising targeted educational materials and behavioral prompts-will be delivered over three months preceding race day.

All study participants will be required to complete the pre-race survey prior to the intervention. The intervention group will complete the SunBeast Educational module once and receive monthly reinforcement messages leading into race day. The SunBeast Educational Program module consists of a 30-minute live, interactive online discussion and infographics/videos on skin cancer, UV index awareness, sunscreen use, protective clothing, and timing of runs. The control group will receive a general wellness brochure via email. The general wellness brochure will contain UV protection information but will also have other general wellness topics.

Conditions
Sun Protection
Being tested
SunBeast Educational module, Control

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SunBeast Educational moduleOther

    consists of a 30-minute live, interactive online discussion and infographics/videos on skin cancer, UV index awareness, sunscreen use, protective clothing, and timing of runs.

  • ControlOther

    general wellness brochure via email

Study groups in NCT07481344
Study groupRoleWhat they receive
InterventionExperimentalThe intervention group will complete the SunBeast Educational module once and receive monthly reinforcement messages leading into race day. The SunBeast Educational Program module consists of a 30-minute live, interactive online discussion and infographics/videos on skin cancer, UV index awareness, sunscreen use, protective clothing, and timing of runs.
Receives: Other: SunBeast Educational module
ControlActive comparatorThe control group will receive a general wellness brochure via email. The general wellness brochure will contain UV protection information but will also have other general wellness topics.
Receives: Other: Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in SEPI scores

    A lower SEPI score indicates lower risk behavior and higher use of sun protective measures.

    Measured: at time of race

  2. Changes in UV protection knowledge

    pre-race and post-race survey of sun protection methods using our knowledge survey.

    Measured: at time of race

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Mar 2026
  2. Study startMay 2027 (estimated)
  3. Primary completionMay 2027 (estimated)
  4. Study completionMay 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
110 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07481344
Sponsor's protocol ID
UMCC 2025.154
Other IDs
HUM00286507
Status last verified
Apr 2026
First submitted
13 Mar 2026
Last updated
24 Apr 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing SunBeast Educational module in people with Sun Protection, run by University of Michigan Rogel Cancer Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 24 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Lauren Yoder (734-936-8051, yoderl@med.umich.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in SEPI scores (time frame: at time of race). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in